Efforts to regenerate cardiac tissue by stimulating myocyte re- entry into the cell division cycle have been limited by the inability of postnatal cardiac myocytes to undergo mitosis. Co- expression of transcription factors active during G1 and S phase can induce exit from GO and DNA replication, however, these cells are blocked in G2. In lower eukaryotes, mitotic entry requires the coordinated expression of many genes, however, mechanisms controlling their transcription remain largely unknown. The characterization of transcriptional activators regulating G2/M transit would significantly advance our understanding of cell division and provide new therapeutic strategies for the regeneration of damaged myocardium. Our long-term goal is to understand the transcriptional regulation of cell division, and how such processes can be manipulated toward myocardial regeneration. Our current approach is to focus on the biology of hCdc5, a novel human phosphoprotein we cloned and demonstrated to be the first transcriptional regulator of G2/M described in mammalian cells. The proposed studies will address the mechanisms by which hCdc5 regulates the cell division cycle.
Our specific aims are to: 1) determine the role of phosphorylation and nuclear import in regulating hCdc5 function by testing nuclear localization signal mutants for nuclear translocation, identifying specific phosphorylation sites by in vitro kinase assay and phosphopeptide mapping, and testing phosphorylation mutants for subcellular localization, transcriptional activity, and effects on G2/M; 2) identify associated proteins which regulate hCdc5 activity using affinity chromatography and a yeast two-hybrid screen; and 3) identify mammalian targets of hCdc5 by selection and amplification of targets, binding site selection in yeast, and cDNA subtraction. These studies will provide basic insights into transcriptional mechanisms for G2/M control as well as reagents for manipulating the cell cycle in non-dividing tissues.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL062174-02
Application #
6184603
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
2
Fiscal Year
2000
Total Cost
$274,120
Indirect Cost
Name
University of California San Francisco
Department
Pediatrics
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Graub, Remo; Lancero, Hope; Pedersen, Anissa et al. (2008) Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processing. Cell Cycle 7:1795-803
Epting, Conrad L; Lopez, Javier E; Pedersen, Anissa et al. (2008) Stem cell antigen-1 regulates the tempo of muscle repair through effects on proliferation of alpha7 integrin-expressing myoblasts. Exp Cell Res 314:1125-35
Williams, S D; Zhu, H; Zhang, L et al. (2006) Adenoviral delivery of human CDC5 promotes G2/M progression and cell division in neonatal ventricular cardiomyocytes. Gene Ther 13:837-43
Epting, Conrad L; Lopez, Javier E; Shen, Xun et al. (2004) Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells. J Cell Sci 117:6185-95
Hlaing, Myint; Spitz, Paul; Padmanabhan, Krishnan et al. (2004) E2F-1 regulates the expression of a subset of target genes during skeletal myoblast hypertrophy. J Biol Chem 279:43625-33
Shen, Xun; Collier, J Michael; Hlaing, Myint et al. (2003) Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 226:128-38
Hlaing, Myint; Shen, Xun; Dazin, Paul et al. (2002) The hypertrophic response in C2C12 myoblasts recruits the G1 cell cycle machinery. J Biol Chem 277:23794-9
Gong, W; Gottlieb, S; Collins, J et al. (2001) Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet 38:E45